+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

Toxoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 282 Pages
  • Global
From
Typhoid Fever Vaccines - Global Strategic Business Report - Product Thumbnail Image

Typhoid Fever Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 372 Pages
  • Global
From
Vaccine Technologies - Global Strategic Business Report - Product Thumbnail Image

Vaccine Technologies - Global Strategic Business Report

  • Report
  • August 2025
  • 573 Pages
  • Global
From
Respiratory Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Respiratory Virus Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 474 Pages
  • Global
From
Rotavirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Rotavirus Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 277 Pages
  • Global
From
Rubella Vaccines - Global Strategic Business Report - Product Thumbnail Image

Rubella Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 275 Pages
  • Global
From
Adult Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adult Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 377 Pages
  • Global
From
Adenovirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adenovirus Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 279 Pages
  • Global
From
Hepatitis A Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis A Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 282 Pages
  • Global
From
Malaria Vaccines - Global Strategic Business Report - Product Thumbnail Image

Malaria Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 371 Pages
  • Global
From
Multivalent Vaccines - Global Strategic Business Report - Product Thumbnail Image

Multivalent Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 278 Pages
  • Global
From
Mumps Vaccines - Global Strategic Business Report - Product Thumbnail Image

Mumps Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 288 Pages
  • Global
From
Nasal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Nasal Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 220 Pages
  • Global
From
Neoantigen Cancer Vaccines - Global Strategic Business Report - Product Thumbnail Image

Neoantigen Cancer Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 380 Pages
  • Global
From
From
From
Oral Typhoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Oral Typhoid Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 183 Pages
  • Global
From
DNA Vaccines - Global Strategic Business Report - Product Thumbnail Image

DNA Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 171 Pages
  • Global
From
Biopharma Buffer - Global Strategic Business Report - Product Thumbnail Image

Biopharma Buffer - Global Strategic Business Report

  • Report
  • August 2025
  • 578 Pages
  • Global
From
Bacterial Vaccines - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 490 Pages
  • Global
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more